DNA methylation signature associated with Bohring-Opitz syndrome: a new tool for functional classification of variants in ASXL genes.
DNA methylation signature associated with Bohring-Opitz syndrome: a new tool for functional classification of variants in ASXL genes.
复制标题
DOI:
10.1038/s41431-022-01083-0
复制
发表时间:
2022-06
影响因子:
5.2
通讯作者:
Weksberg, Rosanna
中科院分区:
文献类型:
--
作者:
Awamleh, Zain;Chater-Diehl, Eric;Choufani, Sanaa;Wei, Elizabeth;Kianmahd, Rebecca R.;Yu, Anna;Chad, Lauren;Costain, Gregory;Tan, Wen-Hann;Scherer, Stephen W.;Arboleda, Valerie A.;Russell, Bianca E.;Weksberg, Rosanna
The additional sex combs-like (ASXL) gene family—encoded by ASXL1, ASXL2, and ASXL3—is crucial for mammalian development. Pathogenic variants in the ASXL gene family are associated with three phenotypically distinct neurodevelopmental syndromes. Our previous work has shown that syndromic conditions caused by pathogenic variants in epigenetic regulatory genes show consistent patterns of genome-wide DNA methylation (DNAm) alterations, i.e., DNAm signatures in peripheral blood. Given the role of ASXL1 in chromatin modification, we hypothesized that pathogenic ASXL1 variants underlying Bohring-Opitz syndrome (BOS) have a unique DNAm signature. We profiled whole-blood DNAm for 17 ASXL1 variants, and 35 sex- and age-matched typically developing individuals, using Illumina’s Infinium EPIC array. We identified 763 differentially methylated CpG sites in individuals with BOS. Differentially methylated sites overlapped 323 unique genes, including HOXA5 and HOXB4, supporting the functional relevance of DNAm signatures. We used a machine-learning classification model based on the BOS DNAm signature to classify variants of uncertain significance in ASXL1, as well as pathogenic ASXL2 and ASXL3 variants. The DNAm profile of one individual with the ASXL2 variant was BOS-like, whereas the DNAm profiles of three individuals with ASXL3 variants were control-like. We also used Horvath’s epigenetic clock, which showed acceleration in DNAm age in individuals with pathogenic ASXL1 variants, and the individual with the pathogenic ASXL2 variant, but not in individuals with ASXL3 variants. These studies enhance our understanding of the epigenetic dysregulation underpinning ASXL gene family-associated syndromes.
登录
查看更多内容
DOI:
10.1002/ajmg.a.62156
发表时间:
2021-06
期刊:
American journal of medical genetics. Part A
影响因子:
--
作者:
Cuddapah VA;Dubbs HA;Adang L;Kugler SL;McCormick EM;Zolkipli-Cunningham Z;Ortiz-González XR;McCormack S;Zackai E;Licht DJ;Falk MJ;Marsh ED
通讯作者:
Marsh ED
影响因子:
50.3
作者:
Abdel-Wahab O;Adli M;LaFave LM;Gao J;Hricik T;Shih AH;Pandey S;Patel JP;Chung YR;Koche R;Perna F;Zhao X;Taylor JE;Park CY;Carroll M;Melnick A;Nimer SD;Jaffe JD;Aifantis I;Bernstein BE;Levine RL
通讯作者:
Levine RL
影响因子:
2.7
作者:
Jeannotte L;Gotti F;Landry-Truchon K
通讯作者:
Landry-Truchon K
影响因子:
9.8
作者:
Choufani, Sanaa;Gibson, William T.;Weksberg, Rosanna
通讯作者:
Weksberg, Rosanna
影响因子:
12.3
作者:
Bainbridge MN;Hu H;Muzny DM;Musante L;Lupski JR;Graham BH;Chen W;Gripp KW;Jenny K;Wienker TF;Yang Y;Sutton VR;Gibbs RA;Ropers HH
通讯作者:
Ropers HH